Dr. Lisa Crossley reports

RELIQ HEALTH TECHNOLOGIES, INC. ANNOUNCES AGREEMENTS TO ADD OVER 10,000 MUSCULOSKELETAL AND RESPIRATORY CONDITION PATIENTS IN 2022

Reliq Health Technologies Inc. has signed implementation plan agreements with current clients that are expected to add over 10,000 new patients to the platform this year, leveraging the new Medicare remote therapeutic monitoring billing codes for patients with musculoskeletal or respiratory conditions.

"As previously disclosed, for 2022, the Centers for Medicare and Medicaid Services (CMS) have expanded their virtual care reimbursement programs to include remote therapeutic monitoring (RTM)," said Dr. Lisa Crossley, chief executive officer of Reliq Health Technologies. "Five new billing codes for RTM were introduced on Jan. 1, 2022. This is consistent with the trend CMS has established over the past four years towards increased reimbursement for virtual care programs that can decrease health care costs by reducing hospitalizations and ER [emergency room] visits. Remote therapeutic monitoring allows clinicians to provide ongoing in-home treatment and monitoring for patients with musculoskeletal and respiratory conditions. RTM involves having patients use medical devices that collect non-physiological data, such as therapy/medication adherence and therapy/medication response, and also allows for patient self-reporting of key metrics such as pain level, mobility, nighttime waking due to breathing difficulties etc. The new RTM codes have increased the eligible patient population for our primary care clients by over 50 per cent and allow orthopedic and respiratory specialists to use Reliq's iUGO Care platform to improve patient care and generate new revenue streams for their specialty practices. The new RTM codes have increased Reliq's target patient population by over 20 million eligible patients. We expect to begin onboarding RTM patients with our existing clients later this month. Based on current implementation plans, we expect to add a minimum of 10,000 new RTM patients this year through our current clients alone at an average revenue of $40 per patient per month."

About Reliq Health Technologies Inc.

Reliq Health Technologies is a rapidly growing global health care technology company that specializes in developing innovative virtual care solutions for the multibillion-dollar health care market. Reliq's powerful iUGO Care platform supports care co-ordination and community-based virtual health care. iUGO Care allows complex patients to receive high-quality care at home, improving health outcomes, enhancing quality of life for patients and families, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture Exchange under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

We seek Safe Harbor.